Literature DB >> 24786460

Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis.

Shameem Mahmood1, Julie Blundell, Anja Drebes, Philip N Hawkins, Ashutosh D Wechalekar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24786460     DOI： 10.1182/blood-2014-02-556514

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis.

Authors:  Dino Veneri; Anna C Giuffrida; Angela Bonalumi; Stefano Calabria; Giorgio Gandini; Achille Ambrosetti; Pietro Minuz
Journal:  Blood Transfus       Date:  2016-05-24       Impact factor: 3.443

Review 2.  Multidisciplinary supportive care in systemic light chain amyloidosis.

Authors:  Bou Zerdan Maroun; Sabine Allam; Chakra P Chaulagain
Journal:  Blood Res       Date:  2022-05-20

3.  Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.

Authors:  Anthony L Nguyen; Muhammad Kamal; Ravi Raghavan; Gayathri Nagaraj
Journal:  Hematol Rep       Date:  2018-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.